NCT06741072
- Conditions
- Chronic Disease, Chronic Kidney Disease, Stage 4, Chronic Kidney Disease, Stage 5, +14 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Post-transplant Lymphoproliferative Disorder
Explore clinical trials studying Post-transplant Lymphoproliferative Disorder. Study availability and eligibility vary by location and protocol.
38 public trials
2 recruiting studies
Post-transplant Lymphoproliferative Disorder trial results
NCT07368634
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +5 more
- Locations
-
- Chinese PLA General Hospital Beijing, China
Not yet recruiting
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)
NCT07573436
- Conditions
- Post-transplant Lymphoproliferative Disorder
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
Active, not recruiting
Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)
NCT06040320
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Active, not recruiting
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
NCT01815749
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Blood Protein Disorders, Burkitt Lymphoma, +64 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
NCT02153580
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, +43 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT03386539
- Conditions
- Behavior, Cardiac Allograft Vasculopathy, Chronic Disease, +19 more
- Locations
-
- Children's of Alabama Birmingham, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Loma Linda University Loma Linda, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
NCT04189835
- Conditions
- DNA Virus Infections, EBV Infection, EBV Viremia, +7 more
- Locations
-
- Aarhus University Hospital Aarhus, Central Region Denmark, Denmark
- Odense University Hospital Odense, Region Syddanmark, Denmark
- Rikshospitalet, Oslo Universitetssykehus Oslo, Norway
NCT02580539
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infections, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada